Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Preferred Stock Liabilities: 2017

Historic Preferred Stock Liabilities for Altimmune (ALT) over the last 1 years, with Dec 2017 value amounting to $9.3 million.

  • Altimmune's Preferred Stock Liabilities was N/A to $510,083 in Q2 2018 from the same period last year, while for Jun 2018 it was $510,083, marking a year-over-year change of. This contributed to the annual value of $9.3 million for FY2017, which is N/A change from last year.
  • Latest data reveals that Altimmune reported Preferred Stock Liabilities of $9.3 million as of FY2017.
  • In the past 5 years, Altimmune's Preferred Stock Liabilities ranged from a high of $9.3 million in FY2017 and a low of $9.3 million during FY2017.
  • Moreover, its 1-year median value for Preferred Stock Liabilities was $9.3 million (2017), whereas its average is $9.3 million.